Therapeutics

Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million

Biocon Founder Kiran Mazumdar-Shaw Celebrates Niece's Bicara Therapeutics Nasdaq Debut

In A First, Researchers Reveal That Killer T Cells In Older Adults Find It Difficult To Recognise Infected Cells